1. Cancer cells resist antibody-mediated destruction by neutrophils through activation of the exocyst complex. Issue 6 (21st June 2022) Authors: van Rees, Dieke J; Bouti, Panagiota; Klein, Bart; Verkuijlen, Paul J H; van Houdt, Michel; Schornagel, Karin; Tool, Anton T J; Venet, David; Sotiriou, Christos; El-Abed, Sarra; Izquierdo, Miguel; Guillaume, Sébastien; Saura, Cristina; Di Cosimo, Serena; Huober, Jens; Roylance, Rebecca; Kim, Sung-... Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab. (5th July 2022) Authors: Ligorio, Francesca; Di Cosimo, Serena; Verderio, Paolo; Ciniselli, Chiara Maura; Pizzamiglio, Sara; Castagnoli, Lorenzo; Dugo, Matteo; Galbardi, Barbara; Salgado, Roberto; Loi, Sherene; Michiels, Stefan; Triulzi, Tiziana; Tagliabue, Elda; El-Abed, Sarra; Izquierdo, Miguel; de Azambuja, Evandro; N... Journal: Journal of the National Cancer Institute Issue: Volume 114:Number 12(2022) Page Start: 1720 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Ten-year survival of neoadjuvant dual HER2 blockade in patients with HER2-positive breast cancer. (March 2023) Authors: Nuciforo, Paolo; Townend, John; Piccart, Martine J.; Fielding, Shona; Gkolfi, Panagiota; El-Abed, Sarra; de Azambuja, Evandro; Werutsky, Gustavo; Bliss, Judith; Moebus, Volker; Colleoni, Marco; Aspitia, Alvaro Moreno; Gomez, Henry; Gombos, Andrea; Coccia-Portugal, Maria A.; Tseng, Ling-Ming; Kunz... Journal: European journal of cancer Issue: Volume 181(2023) Page Start: 92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03). Issue 5 (10th February 2022) Authors: Mayer, Erica L.; Fesl, Christian; Hlauschek, Dominik; Garcia-Estevez, Laura; Burstein, Harold J.; Zdenkowski, Nicholas; Wette, Viktor; Miller, Kathy D.; Balic, Marija; Mayer, Ingrid A.; Cameron, David; Winer, Eric P.; Ponce Lorenzo, José Juan; Lake, Diana; Pristauz-Telsnigg, Gunda; Haddad, Tufia ... Journal: Journal of clinical oncology Issue: Volume 40:Issue 5(2022) Page Start: 449 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D). (May 2021) Authors: Moreno-Aspitia, Alvaro; Holmes, Eileen M.; Jackisch, Christian; de Azambuja, Evandro; Boyle, Frances; Hillman, David W.; Korde, Larissa; Fumagalli, Debora; Izquierdo, Miguel A.; McCullough, Ann E.; Wolff, Antonio C.; Pritchard, Kathleen I.; Untch, Michael; Guillaume, Sébastien; Ewer, Michael S.; ... Journal: European journal of cancer Issue: Volume 148(2021) Page Start: 287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗